UnitedHealth Group, US91324P1021

UnitedHealth Group stock trades 28.19 percent below its 52-week high

Published on 10/05/2026 at 09:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 2026 adjusted EPS reached USD 6.38 versus USD 4.08. UnitedHealth Group stock costs EUR 331.50 on October 5, 2026 after EUR 330.40.

Overhead-Flatlay mit Pillendosen, Blisterpackungen, Stethoskop und Klemmbrett auf weißem Marmor
UnitedHealth Group US91324P1021 symbolisiert durch Pharmacy-Flatlay mit Medikamenten Stethoskop Blisterpack und Klemmbrett, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) was trading at EUR 331.50 at Lang & Schwarz on October 5, 2026 at 9:08 a.m. CEST, 28.19 percent below its 52-week high of EUR 461.62. On September 15, UnitedHealth Group announced that it will release third-quarter 2026 results on October 13 before the market opens.

Second-quarter earnings reset

The latest operating picture is materially stronger than the year-earlier comparison. In the second quarter of 2026, adjusted earnings per share reached USD 6.38, up from USD 4.08 in the second quarter of 2025, while revenue totaled USD 112.00 billion, according to Fortune on July 16, 2026.

The medical care ratio also improved to 86.70 percent from 89.40 percent in the year-earlier quarter. Operating earnings reached USD 8.00 billion and grew 55.00 percent year over year, giving the recovery a measurable earnings component beyond revenue stability.

Guidance meets analyst expectations

Management raised its fiscal 2026 adjusted earnings per share guidance to USD 19.50-20.00 and increased planned 2026 share repurchases to at least USD 5.00 billion from an initial USD 2.50 billion, as reported in the July 16 earnings call by Fortune.

As of September 18, 2026, MarketBeat reported a Moderate Buy consensus from 27 research firms, including 19 Buy ratings, seven Holds and one Strong Buy. The average 12-month price target was USD 456.56, while elevated medical costs and the slower commercial-margin recovery remain central variables for the October results.

Stock remains below yearly high

At EUR 331.50, the Lang & Schwarz quote stood EUR 128.90 below the prior close of EUR 330.40? No, the price was EUR 1.10 above that close, equal to plus 0.33 percent. The primary listing is on the NYSE, where the finance quote showed USD 371.90 on October 2, 2026, with a market capitalization of USD 337.7 billion and a 52-week range of USD 255.97 to USD 461.62.

The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.

UnitedHealth Group stock facts

  • Company: UnitedHealth Group Incorporated
  • ISIN: US91324P1021
  • Ticker: UNH
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 5, 2026, 9:08 a.m. CEST: EUR 331.50
  • Change versus prior close: plus 0.33 percent
  • Prior close Lang & Schwarz October 2, 2026: EUR 330.40
  • Market capitalization: USD 337.7 billion as of October 2, 2026
  • 52-week range: USD 255.97-461.62 as of October 2, 2026
  • Sector / Industry: Healthcare / Medical - Healthcare Plans

More news and analyses on UnitedHealth Group stock

Disclaimer...

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 70230682 | bgmi